223 related articles for article (PubMed ID: 34362454)
1. Impact of human adipose tissue-derived stem cells on dermatofibrosarcoma protuberans cells in an indirect co-culture: an in vitro study.
Yuan Z; Zhu Z; Zhu F; Ding F; Wang Y; Wang X; Luo X; Yang J; Liu F; Sun D
Stem Cell Res Ther; 2021 Aug; 12(1):440. PubMed ID: 34362454
[TBL] [Abstract][Full Text] [Related]
2. Impact of Human Adipose Tissue-Derived Stem Cells on Malignant Melanoma Cells in An In Vitro Co-culture Model.
Preisner F; Leimer U; Sandmann S; Zoernig I; Germann G; Koellensperger E
Stem Cell Rev Rep; 2018 Feb; 14(1):125-140. PubMed ID: 29064018
[TBL] [Abstract][Full Text] [Related]
3. The impact of human adipose tissue-derived stem cells on breast cancer cells: implications for cell-assisted lipotransfers in breast reconstruction.
Koellensperger E; Bonnert LC; Zoernig I; Marmé F; Sandmann S; Germann G; Gramley F; Leimer U
Stem Cell Res Ther; 2017 May; 8(1):121. PubMed ID: 28545495
[TBL] [Abstract][Full Text] [Related]
4. Alterations of gene expression and protein synthesis in co-cultured adipose tissue-derived stem cells and squamous cell-carcinoma cells: consequences for clinical applications.
Koellensperger E; Gramley F; Preisner F; Leimer U; Germann G; Dexheimer V
Stem Cell Res Ther; 2014 May; 5(3):65. PubMed ID: 24887580
[TBL] [Abstract][Full Text] [Related]
5. Current treatment options for dermatofibrosarcoma protuberans.
Rutkowski P; Debiec-Rychter M
Expert Rev Anticancer Ther; 2015; 15(8):901-9. PubMed ID: 26027711
[TBL] [Abstract][Full Text] [Related]
6. Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1.
Oyama R; Kito F; Qiao Z; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2019 Jan; 55(1):62-73. PubMed ID: 30411273
[TBL] [Abstract][Full Text] [Related]
7. Dermatofibrosarcoma Protuberans.
Allen A; Ahn C; Sangüeza OP
Dermatol Clin; 2019 Oct; 37(4):483-488. PubMed ID: 31466588
[TBL] [Abstract][Full Text] [Related]
8. Dermatofibrosarcoma Protuberans.
Reha J; Katz SC
Surg Clin North Am; 2016 Oct; 96(5):1031-46. PubMed ID: 27542641
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of NCC-DFSP3-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Nakagawa M; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Jul; 33(3):894-903. PubMed ID: 32356243
[TBL] [Abstract][Full Text] [Related]
10. Phenotype and proliferation characteristics of cultured spindle-shaped cells obtained from normal human skin and lesions of dermatofibroma, Kaposi's sarcoma, and dermatofibrosarcoma protuberans: a comparison with fibroblast and endothelial cells of the dermis.
Bonish BK; Foreman KE; Gutierrez-Steil C; Nickoloff BJ
J Dermatol Sci; 1997 Nov; 16(1):52-8. PubMed ID: 9438908
[TBL] [Abstract][Full Text] [Related]
11. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.
Llombart B; Serra-Guillén C; Monteagudo C; López Guerrero JA; Sanmartín O
Semin Diagn Pathol; 2013 Feb; 30(1):13-28. PubMed ID: 23327727
[TBL] [Abstract][Full Text] [Related]
12. Current Update on the Molecular Biology of Cutaneous Sarcoma: Dermatofibrosarcoma Protuberans.
Iwasaki T; Yamamoto H; Oda Y
Curr Treat Options Oncol; 2019 Mar; 20(4):29. PubMed ID: 30874910
[TBL] [Abstract][Full Text] [Related]
13. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing.
Seo E; Lim JS; Jun JB; Choi W; Hong IS; Jun HS
J Transl Med; 2017 Feb; 15(1):35. PubMed ID: 28202074
[TBL] [Abstract][Full Text] [Related]
15. S1 guidelines for dermatofibrosarcoma protuberans (DFSP) - update 2018.
Ugurel S; Kortmann RD; Mohr P; Mentzel T; Garbe C; Breuninger H; Bauer S; Grabbe S
J Dtsch Dermatol Ges; 2019 Jun; 17(6):663-668. PubMed ID: 31115967
[TBL] [Abstract][Full Text] [Related]
16. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
Koseła-Paterczyk H; Rutkowski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.
Sjöblom T; Shimizu A; O'Brien KP; Pietras K; Dal Cin P; Buchdunger E; Dumanski JP; Ostman A; Heldin CH
Cancer Res; 2001 Aug; 61(15):5778-83. PubMed ID: 11479215
[TBL] [Abstract][Full Text] [Related]
18. [Dermatofibrosarcoma protuberans].
Ugurel S
Hautarzt; 2008 Nov; 59(11):933-9; quiz 940. PubMed ID: 18936902
[TBL] [Abstract][Full Text] [Related]
19. Dermatofibrosarcoma protuberans: recent clinical progress.
McArthur G
Ann Surg Oncol; 2007 Oct; 14(10):2876-86. PubMed ID: 17647063
[TBL] [Abstract][Full Text] [Related]
20. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues.
Wang J; Hisaoka M; Shimajiri S; Morimitsu Y; Hashimoto H
Diagn Mol Pathol; 1999 Sep; 8(3):113-9. PubMed ID: 10565681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]